相似文献
1
Antifungal agents for common paediatric infections.
Paediatr Child Health. 2000 Nov;5(8):477-91. doi: 10.1093/pch/5.8.477.
2
Update on antifungal agents for paediatric patients.
Clin Microbiol Infect. 2010 Sep;16(9):1343-53. doi: 10.1111/j.1469-0691.2010.03334.x.
3
Antifungal chemoprophylaxis in children and adolescents with haematological malignancies and following allogeneic haematopoietic stem cell transplantation: review of the literature and options for clinical practice.
Drugs. 2012 Mar 26;72(5):685-704. doi: 10.2165/11599810-000000000-00000.
4
Efficacy, safety and feasibility of antifungal prophylaxis with posaconazole tablet in paediatric patients after haematopoietic stem cell transplantation.
J Cancer Res Clin Oncol. 2017 Jul;143(7):1281-1292. doi: 10.1007/s00432-017-2369-7. Epub 2017 Mar 3.
5
Liposomal amphotericin B: a review of its use as empirical therapy in febrile neutropenia and in the treatment of invasive fungal infections.
Drugs. 2009;69(3):361-92. doi: 10.2165/00003495-200969030-00010.
6
Epidemiology of invasive fungal infections in neonates and children.
Clin Microbiol Infect. 2010 Sep;16(9):1321-7. doi: 10.1111/j.1469-0691.2010.03288.x.
7
A seven-year surveillance study of the epidemiology, antifungal susceptibility, risk factors and mortality of candidaemia among paediatric and adult inpatients in a tertiary teaching hospital in China.
Antimicrob Resist Infect Control. 2020 Aug 14;9(1):133. doi: 10.1186/s13756-020-00798-3.
8
Antifungal consumption, indications and selection of antifungal drugs in paediatric tertiary hospitals in Turkey: Results from the first national point prevalence survey.
J Glob Antimicrob Resist. 2018 Dec;15:232-238. doi: 10.1016/j.jgar.2018.08.007. Epub 2018 Aug 16.
9
Commonly used antibacterial and antifungal agents for hospitalised paediatric patients: implications for therapy with an emphasis on clinical pharmacokinetics.
Paediatr Drugs. 2001;3(10):733-61. doi: 10.2165/00128072-200103100-00003.
10
Genotypic diversity and antifungal susceptibility of Cryptococcus neoformans isolates from paediatric patients in China.
Mycoses. 2019 Feb;62(2):171-180. doi: 10.1111/myc.12863. Epub 2018 Nov 13.
引用本文的文献
1
Antifungal agents for common paediatric infections.
Can J Infect Dis Med Microbiol. 2008 Jan;19(1):15-8.
2
Antifungal agents for common paediatric infections.
Paediatr Child Health. 2007 Dec;12(10):875-83. doi: 10.1093/pch/12.10.875.
本文引用的文献
1
Incidence and pathogenesis of neonatal candidiasis.
Pediatrics. 1958 Mar;21(3):421-9.
2
Therapeutic evaluation of nystatin and amphotericin in oral moniliasis in infants and children.
Antibiot Annu. 1957;5:59-64.
3
Cutaneous candidiasis in early infancy and childhood.
Pediatrics. 1957 Nov;20(5, Part 1):827-34.
4
Thrush napkin rashes.
Br Med J. 1956 Apr 7;1(4970):782-4. doi: 10.1136/bmj.1.4970.782.
5
Dermatophyte infections in children.
Adv Pediatr Infect Dis. 1999;14:73-107.
6
Ketoconazole 2% shampoo in the treatment of tinea versicolor: a multicenter, randomized, double-blind, placebo-controlled trial.
J Am Acad Dermatol. 1998 Dec;39(6):944-50. doi: 10.1016/s0190-9622(98)70267-1.
7
Twelve weeks of continuous oral therapy for toenail onychomycosis caused by dermatophytes: a double-blind comparative trial of terbinafine 250 mg/day versus itraconazole 200 mg/day.
J Am Acad Dermatol. 1998 May;38(5 Pt 3):S57-63. doi: 10.1016/s0190-9622(98)70486-4.
8
Terbinafine versus itraconazole: a controlled clinical comparison in onychomycosis of the toenails.
J Am Acad Dermatol. 1998 May;38(5 Pt 3):S53-6. doi: 10.1016/s0190-9622(98)70485-2.
9
An overview of topical antifungal therapy in dermatomycoses. A North American perspective.
Drugs. 1998 May;55(5):645-74. doi: 10.2165/00003495-199855050-00004.
10
Systemic antifungal agents. Drug interactions of clinical significance.
Drug Saf. 1998 Feb;18(2):83-97. doi: 10.2165/00002018-199818020-00001.
Zotero 插件